Esperion Therapeutics, Inc.To Present At BioCentury’s Newsmakers In The Biotech Industry Conference

Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced the Company will present at the BioCentury NewsMakers in the Biotech Industry Conference in New York City, N.Y. The presentation will take place on Friday, September 26 at 8:30 a.m. Eastern Time, when Tim M. Mayleben, president and chief executive officer, will provide an update on the company.

Help employers find you! Check out all the jobs and post your resume.